Severe Immune-related Adverse Events and Their Effect on Survival in Patients With Advanced Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors.

Saved in:
Bibliographic Details
Title: Severe Immune-related Adverse Events and Their Effect on Survival in Patients With Advanced Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors.
Authors: Nojiri T; Department of General Thoracic Surgery, Higashiosaka City Medical Center, Higashiosaka, Japan., Omura A; Department of General Thoracic Surgery, Higashiosaka City Medical Center, Higashiosaka, Japan.; Department of Palliative Medicine, Himeji St. Mary's Hospital, Himeji, Japan., Nishimura H; Department of General Thoracic Surgery, Higashiosaka City Medical Center, Higashiosaka, Japan., Iede K; Department of Clinical Oncology, Higashiosaka City Medical Center, Higashiosaka, Japan., Takeyasu Y; Department of Thoracic Oncology, Kansai Medical University, Hirakata, Japan., Katsushima U; Department of Thoracic Oncology, Kansai Medical University, Hirakata, Japan., Higashiyama M; Department of General Thoracic Surgery, Higashiosaka City Medical Center, Higashiosaka, Japan.
Source: Cancer diagnosis & prognosis [Cancer Diagn Progn] 2026 Jan 03; Vol. 6 (1), pp. 106-113. Date of Electronic Publication: 2026 Jan 03 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 9918316186306676 Publication Model: eCollection Cited Medium: Internet ISSN: 2732-7787 (Electronic) Linking ISSN: 27327787 NLM ISO Abbreviation: Cancer Diagn Progn Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2732-7787
DOI:10.21873/cdp.10511